This podcast was planned in collaboration with the American College of Clinical Pharmacy (ACCP) Ambulatory Care PRN. The glucagon-like peptide-1 (GLP-1) receptors agonists have documented benefits in an expanding array of patient populations are not longer simply "diabetes" and "obesity" medications.

Expert Panelists: Lauren Cunningham, PharmD, BCACP, CDCES and Kylee Funk, PharmD, BCPS